Cash and Cash Equivalents, at Carrying Value in USD of Regen BioPharma Inc from Q1 2012 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Regen BioPharma Inc quarterly Cash and Cash Equivalents, at Carrying Value history and change rate from Q1 2012 to Q4 2024.
  • Regen BioPharma Inc Cash and Cash Equivalents, at Carrying Value for the quarter ending 31 Dec 2024 was $135.000.
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

Regen BioPharma Inc Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $135 31 Dec 2024 10-Q 16 May 2025
Q3 2024 $716 -$120K -99.4% 30 Sep 2024 10-Q 16 May 2025
Q3 2023 $121K +$69.8K +136% 30 Sep 2023 10-K 13 May 2025
Q3 2022 $51.2K -$676K -93% 30 Sep 2022 10-K 15 Nov 2022
Q4 2021 $353K +$353K 31 Dec 2021 10-Q 20 Jan 2022
Q3 2021 $727K +$727K 30 Sep 2021 10-K 15 Nov 2022
Q2 2021 $188K +$188K 30 Jun 2021 10-Q/A 22 Dec 2021
Q1 2021 $0 $0 31 Mar 2021 10-Q 18 Aug 2021
Q4 2020 $0 -$357 -100% 31 Dec 2020 10-Q 13 Aug 2021
Q3 2020 $0 -$7.86K -100% 30 Sep 2020 10-Q 18 Aug 2021
Q2 2020 $0 -$1.81K -100% 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 $0 -$15.1K -100% 31 Mar 2020 10-Q 18 Aug 2021
Q4 2019 $357 -$38.7K -99.1% 31 Dec 2019 10-Q 13 Aug 2021
Q3 2019 $7.86K -$164 -2.05% 30 Sep 2019 10-K 22 Dec 2021
Q2 2019 $1.81K -$53.6K -96.7% 30 Jun 2019 10-Q 05 Aug 2021
Q1 2019 $15.1K -$16K -51.4% 31 Mar 2019 10-Q 05 Aug 2021
Q4 2018 $39.1K -$223K -85.1% 31 Dec 2018 10-Q 05 Aug 2021
Q3 2018 $8.02K -$262K -97% 30 Sep 2018 10-Q 05 Aug 2021
Q2 2018 $55.4K -$346K -86.2% 30 Jun 2018 10-Q 24 Oct 2019
Q1 2018 $31.1K -$82.1K -72.5% 31 Mar 2018 10-Q 29 Aug 2019
Q4 2017 $262K 31 Dec 2017 10-Q 12 Feb 2019
Q3 2017 $270K +$245K +988% 30 Sep 2017 10-K 21 Jun 2021
Q2 2017 $402K 30 Jun 2017 10-Q 06 Aug 2018
Q1 2017 $113K +$7.14K +6.73% 31 Mar 2017 10-Q 14 May 2018
Q3 2016 $24.8K -$13.8K -35.7% 30 Sep 2016 10-K 27 Dec 2018
Q1 2016 $106K -$416K -79.7% 31 Mar 2016 10-Q 29 Apr 2016
Q4 2015 $169K +$115K +214% 31 Dec 2015 10-Q 28 Jan 2016
Q3 2015 $38.6K +$38.6K 30 Sep 2015 10-Q 27 Jan 2017
Q1 2015 $522K 31 Mar 2015 10-Q 29 Apr 2016
Q4 2014 $53.6K 31 Dec 2014 10-Q/A 28 Apr 2017
Q3 2014 $0 -$116K -100% 30 Sep 2014 10-Q 01 Aug 2016
Q2 2014 $49.4K 30 Jun 2014 10-Q/A 28 Apr 2017
Q3 2013 $116K +$115K +12467% 30 Sep 2013 10-K/A 28 Apr 2017
Q3 2012 $923 30 Sep 2012 10-K 18 Dec 2014
Q1 2012 $0 23 Apr 2012 10-Q 07 Aug 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.